Synthesis and characterization of inclusion complex of the vasodilator drug minoxidil with β-cyclodextrin

Journal of Inclusion Phenomena and Macrocyclic Chemistry

Volumn 60, Issue 3-4, 2008, Pages 369-377

  Calderini, A ^a   Pessine, F B T ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

B Cyclodextrin; DOSY; Inclusion complex; Minoxidil; NMR; ROESY

Indexed keywords

EID: 41549083307     PISSN: 09230750     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10847-007-9387-z     Document Type: Article

References (19)

1. Szejtli, J.: Introduction and general overview of cyclodextrin chemistry. Chem. Rev. 98, 1743-1753 (1998)
2. Connors, K.A.: The stability of cyclodextrin complexes in solution. Chem. Rev. 97, 1325-1358 (1997)
3. Szejtli, J.: Cyclodextrin Technology. Kluwer, Dordrecht (1988)
4. Eftink, M.R, Andy, M.L., Bystrom, K., Perlmutter, H.D., Kristol, D.S.: Cyclodextrin inclusion complexes: studies in the size of alicyclic guests. J. Am. Chem. Soc. 111, 6765-6772 (1989)
5. Uekama, K., Hirayama, F., Irie, T.: Cyclodextrin drug carrier systems. Chem. Rev. 98, 2045-2076 (1998)
6. Loftsson, T., Brewster, M.E.: Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J. Pharm. Sci. 85, 1017 (1996)
7. Gorecki, D.K.J.: Minoxidil. Anal. Prof. Drug Subst. 17, 185-219 (1988)
8. 2O: a comparative study. Carbohydrate Res. 341, 70-274 (2006)
9. Kurozumi, M., Nambu, N., Nagai, T.: Inclusion compounds of non steroidal anti-inflammatory and other slightly water soluble drugs with α- and β-cyclodextrins in powdered form. Chem. Pharm. Bull. 23, 3062-3068 (1975)
10. Job, P.: Reserches sur la formation de complexes mineraux en solution et sur leur stabilité. Ann. Chim. 9, 113-203 (1928)
11. Higuchi, T., Connors, K.A.: Phase solubility techniques. Adv. Anal. Chem. Instr. 4, 117-212 (1965)
12. Giordano, F., Novak, C., Moyano, J.R.: Thermal analysis of cyclodextrins and their inclusion compounds. Thermochim. Acta 380, 123-151 (2001)
13. Kim, J., Lee, M., Rang, M.: Minoxidil-containing dosage forms: substantivity and after-rinsing hair growth promotion. Drug Deliv. 10(2), 119-123 (2003)
14. Thakkar, A.L., Demarco, P.V.: Cycloheptaamylose inclusion complexes of barbutirates: correlation between proton magnetic resonance and solubility studies. J. Pharm. Sci. 60, 652-653 (1971)
15. Schneider, H.J., Hacket, F., Rüdiger, V.: NMR studies of cyclodextrins and cyclodextrin complexes. Chem. Rev. 98(5), 1755-1786 (1998)
16. Greatbanks, D., Pickford, R.: Cyclodextrins as chiral complexing agents in water, and their application to optical purity measurements. Magn. Reson. Chem. 25, 208-213 (1987)
17. Bax, A., Davis, D.G.J.: Practical aspects of two-dimensional transverse NOE spectroscopy. Magn. Reson. 63, 207-213 (1985)
18. Rymdén, R., Carlfors, J., Stilbs, P.: Substrate binding to cyclodextrins in aqueous solution: a multicomponent self-diffusion study. J. Incl. Phenom. 1(2), 159-167 (1983)
19. Lin, M., Jayawickrama, D.A., Rose, R.A., DelViscio, J.A., Larive, C.K.: Nuclear magnetic resonance spectroscopic analysis of the selective complexation of the cis and trans isomers of phenylalanylproline by β-cyclodextrin. Anal. Chim. Acta 307, 449-457 (1995)